share_log

UBS Downgrades CareMax to Neutral, Lowers Price Target to $1

UBS Downgrades CareMax to Neutral, Lowers Price Target to $1

瑞银将CareMax评级下调至中性,将目标股价下调至1美元
Benzinga ·  2023/11/17 05:01

UBS analyst A.J. Rice downgrades CareMax (NASDAQ:CMAX) from Buy to Neutral and lowers the price target from $5 to $1.

瑞银分析师A.J. Rice将CareMax(纳斯达克股票代码:CMAX)的评级从买入下调至中性,并将目标股价从5美元下调至1美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发